XML 29 R7.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net income $ 2,511 $ 2,089
Provision for depreciation and net amortization 1,069 974
Provision for loan losses 790 1,045
Deferred net loan origination costs (156) (135)
Gain on sale of loans (401) (412)
Provision for (recapture of) servicing right valuation allowance (145) 7
Loss on sale of foreclosed assets 433 28
Loss on sale of securities 0 20
Increase in cash surrender value of life insurance (208) (204)
Accrued interest receivable 166 (105)
Other assets 131 213
Other liabilities (556) (314)
Net cash provided by operating activities 3,634 3,206
Proceeds from sale and maturities of:    
Securities available for sale 7,930 13,628
Securities held to maturity 2,230 0
Payment for purchase of:    
Securities available for sale (13,941) (14,674)
Securities held to maturity (831) 0
Net increase in loans (6,500) (7,962)
Capital expenditures (102) (735)
Proceeds from sale of foreclosed assets 330 475
Purchase of bank-owned life insurance (92) 0
Net cash used in investing activities (10,976) (9,268)
Cash flows from financing activities:    
Net decrease in non-interest-bearing deposits (2,472) (5,285)
Net increase (decrease) in interest-bearing deposits (14,118) 1,398
Net increase (decrease) in FHLB advances 1,690 (725)
Net decrease in other borrowings (6,372) (3,546)
Dividends declared (586) (565)
Proceeds from exercise of stock options 24 0
Net cash used in financing activities (21,834) (8,723)
Net decrease in cash and cash equivalents (29,176) (14,785)
Cash and cash equivalents at beginning 40,331 26,337
Cash and cash equivalents at end 11,155 11,552
Cash paid during the period for:    
Interest 4,591 5,625
Income taxes 1,025 423
Loans charged off 1,083 995
Loans transferred to foreclosed assets 135 2,950
Issuance of unvested restricted stock grants at fair value 200 75
Vesting of restricted stock grants $ 45 $ 21